|
?:authorAffiliation
|
-
[\'Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA. dmenter@mdanderson.org.\', \'Division of Internal Medicine, Benign Hematology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.\', \'Department of GI Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.\', \'Department of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.\', \'Department of Pathology, Bioactive Lipids Research Program, Wayne State University, 5101 Cass Ave. 430 Chemistry, Detroit, MI, 48202, USA.\', \'Department of Pathology, Wayne State University School of Medicine, 431 Chemistry Bldg, Detroit, MI, 48202, USA.\', \'Cancer Biology Division, Wayne State University School of Medicine, 431 Chemistry Bldg, Detroit, MI, 48202, USA.\', \'Department of Gynecologic Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA.\', \'Center for RNA Interference and Non-Coding RNA, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.\', \'Department of Cancer Biology, The University of Texas MD Anderson Cancer Center, Houston, TX, 77030, USA.\']
|
![[This page as RDF]](https://research.tib.eu/covid-19/static/rdf-icon.gif){kind=icon}